NOTE: This video is ONLY available to watch in selected countries and geographies [geoip-content country=”AT, BE, BG, HR, CY, CZ, DK, EE, FI, FR, DE, GR, HU, IE, IT, LV, LT, LU, MT, NL, PL, PT, RO, SK, SI, CH, ES, SE, GB, AL, AD, AM, AZ, BY, BA, GE, IS, KZ, LI, MD, MC, ME, MK, NO, RU, SM, RS, CH, TR, UA, VA”]
Ross Milner (University of Chicago, Chicago, USA) outlines how long-term data from the unique GREAT registry supports the use of Gore’s aortic solutions.
The worldwide GREAT registry was initiated in 2010 to evaluate how Gore’s aortic devices perform in real-world, on- and off-label cases. Approximately 5,000 patients have been enrolled, to collect 10-year follow-up data.
“I think we’ve all learned from the international experience we’ve had with the registry, really looking at different parts of the aortic treatments we do, and looking at the outcomes that we have, and we can learn from those experiences,” says Milner, who has particular interest and clinical expertise with the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE) device.
According to data from the registry, the device has done well in terms of aneurysm performance, limb patency and internal branch patency, and has also been associated with fewer reinterventions compared to other treatment options in this space, he details.
On the larger issue of durability of devices, Milner notes that this is a question “I think all of us ask ourselves, not just because of the devices we place, but because of the patients we see long term, and the registry to date shows very durable outcomes. I think the 10-year data will be even more valuable […] but the data so far has shown really outstanding durability.”
This video was sponsored by W.L. Gore & Associates.
[/geoip-content]
